QGEN - Spark Newswire

3 minute read

QIAGEN Partners with Verogen to Offer Broadest Portfolio for Human Identification, Including Next Generation Sequencing Solutions

Today, 5:21 PM

QIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA)))) today announced a commercialization partnership with San Diego-based human identification specialist Verogen that will provide customers of both companies with

QGEN

5 minute read

The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy’s Launches Generic Vascepa, Halozyme Strikes Licensing Deal

By Shanthi Rexaline

Today, 5:21 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21)

ABCL

1 minute read

Qiagen Launches CRISPR-Specific Products For Gene-Editing Experiments

By Vandana Singh

Today, 5:21 PM

Qiagen NV (NYSE:QGEN) has launched dedicated solutions specific to CRISPR technology used for editing genomes and modifying gene function. QiaPrep&Amp CRISPR…

QGEN

2 minute read

News

QIAGEN Launches Dedicated CRISPR Products for Rapid and Simplified Analysis of Gene-Editing Experiments

By Benzinga Newsdesk

Today, 5:21 PM

QIAprep&amp CRISPR Kit and Q-Primer Solutions expand QIAGEN portfolio for CRISPR applications Products are highly sensitive tools for characterizing the impact of CRISPR editing experiments Solutions

CRSP

10 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For June 3, 2021

By Benzinga Insights

Today, 5:21 PM

ADC

1 minute read

Amgen’s First KRAS-Targeted Therapy, Lumakras Scores FDA Approval For Lung Cancer

By Vandana Singh

Today, 5:21 PM

The FDA has given accelerated approval to Amgen Inc’s (NASDAQ:AMGN) Lumakras (sotorasib) for non-small cell lung cancer (NSCLC) patients harboring kras mutation.…

AMGN

3 minute read

News

QIAGEN Highlights Launch Of Expanded Scope Of Companion Diagnostic Claims For Therascreen Kit

By Bill Haddad

Today, 5:21 PM

QIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA)) today announced the launch of an expanded scope of companion diagnostic (CDx) claims for the therascreen® KRAS RGQ PCR Kit (therascreen KRAS Kit) after it

QGEN

8 minute read

Uncategorized

Earnings Scheduled For May 3, 2021

By Benzinga Insights

Today, 5:21 PM

Companies Reporting Before The Bell • Scienjoy Holding (NASDAQ:SJ) is estimated to report quarterly earnings at $0.58 per share on revenue of $540.11 million.

ADC

8 minute read

Uncategorized

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge

By Shanthi Rexaline

Today, 5:21 PM

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions.

ABUS

4 minute read

Uncategorized

QIAGEN Announced Launch of New LIAISON LymeDetect Assay Based on QuantiFERON Technology in Countries Accepting CE Mark for Early Diagnosis of Lyme Borreliosis

By Charles Gross

Today, 5:21 PM

QIAGEN N.V. (NYSE: QGEN) and DiaSorin (FTSE MIB: DIA) today announced the launch of the LIAISON® LymeDetect® Assay for markets accepting the CE Mark, as an aid to detect early Lyme Borreliosis infection (Lyme) on LIAISON® analyzer systems.

QGEN

Feed Symbols: QGEN